Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
| dc.contributor.author | Newland, Adrian C. | |
| dc.contributor.author | Sánchez-González, Blanca | |
| dc.contributor.author | Rejtő, László | |
| dc.contributor.author | Egyed, Miklós | |
| dc.contributor.author | Romanyuk, Nataliya | |
| dc.contributor.author | Godar, Marie | |
| dc.contributor.author | Verschueren, Katrien | |
| dc.contributor.author | Gandini, Domenica | |
| dc.contributor.author | Ulrichts, Peter | |
| dc.contributor.author | Beauchamp, Jon | |
| dc.contributor.author | Dreier, Torsten | |
| dc.contributor.author | Ward, E. Sally | |
| dc.contributor.author | Michel, Marc | |
| dc.contributor.author | Liebman, Howard A. | |
| dc.contributor.author | Haard, Hans de | |
| dc.contributor.author | Leupin, Nicolas | |
| dc.contributor.author | Kuter, David J. | |
| dc.date.accessioned | 2023-09-11T09:03:04Z | |
| dc.date.available | 2023-09-11T09:03:04Z | |
| dc.date.issued | 2019 | |
| dc.date.oa | 2023-10-17 | |
| dc.date.pasync | 2023-10-17T23:10:43Z | |
| dc.date.updated | 2023-09-11T09:03:04Z | |
| dc.description.corrector | kzs | |
| dc.identifier.citation | American Journal Of Hematology. -95 : 2 (2019), p. 178-187. -Am. J. Hematol. - 0361-8609. - 1096-8652 | |
| dc.identifier.doi | http://dx.doi.org/10.1002/ajh.25680 | |
| dc.identifier.issn | 1096-8652 | |
| dc.identifier.issn | 0361-8609 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM114546 | |
| dc.identifier.scopus | 85076349302 | |
| dc.identifier.uri | https://hdl.handle.net/2437/358839 | |
| dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1002/ajh.25680 | |
| dc.identifier.wos | 000501681500001 | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.owner | szerző | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_5_Phase 2 study of efgartigimod.pdf
- Méret:
- 1.76 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat